Skip to content
Gamora Global

The Zimbabwean Government Declines ‘Lopsided’ American Healthcare Assistance Package Because of Information Fears

Medical funding illustration
The offered US funding was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has rejected a major American healthcare agreement valued at $367m (272 million pounds) over five years over the United States' request for confidential data.

This move came to light following a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "skewed".

A government representative later clarified that the US was requesting health data for research and profit but was not willing to share the resulting advantages from future vaccines.

"We will now turn to the difficult and regrettable task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for continued negotiations to find a deal agreeable to both sides so the nation's critical HIV programme can be sustained.

Broader Context

This development comes after a comparable situation in Kenya, where a court halted a similar deal with the US following concerns were filed about the safety of Kenyans' medical information.

Since returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.

The agency had administered aid for the US government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral deals to boost transparency and accountability.

Based on statements, 16 African countries have to date agreed to these new agreements, representing more than $18.3bn in committed funds.

Specifics of the Rejected Deal

The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this cooperation could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded programmes," the Ambassador added.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"Our nation was requested to share its biological resources and data indefinitely, with no corresponding guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," he stated.

"Put simply, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be available to our people if a new disease outbreak arise."

National Interest and International Frameworks

He also said that the US's withdrawal from the global health body and its push of one-on-one health agreements were upending structures already set up via the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.

"This system is intended to guarantee that when a nation provides its data, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."

The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We encourage ongoing dialogue with our US partners on how future co-operation could be arranged in a way that honours the independence and dignity of both nations."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but urged that talks should continue considering much of the country's HIV programmes depended on foreign aid.

"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," it added.

The halted deal highlights the complex debate between receiving vital foreign assistance and safeguarding local interests in an ever more data-driven world.

TA
About the author

Taylor Alvarez

A digital strategist with over a decade of experience in tech consulting and innovation across European markets.

Gamora Global

Type to search articles.